Anne VanLent
Director/Board Member at TREVI THERAPEUTICS, INC.
Net worth: 89 641 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jennifer Good | F | 59 | 13 years | |
Stuart Essig | M | 62 | 27 years | |
Steven Fruchtman | M | 73 | 9 years | |
Ed Mathers Mathers | M | 64 | 9 years | |
Fabien de Ladonchamps | M | 45 | 11 years | |
David Fellows | M | 67 | 2 years | |
Mark Feinberg | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
James Marino | M | 74 | 9 years | |
Chris Hollowood | M | 50 | 2 years | |
Jeffrey Mosebrook | M | 47 | 18 years | |
Mark Guerin | M | 55 | 11 years | |
Thomas Sciascia | M | 70 |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | 13 years |
Luigi Marro | M | - | 3 years | |
Robert Goldberg | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Jeffrey Vega | M | 56 |
Princeton Area Community Foundation
Princeton Area Community Foundation Miscellaneous Commercial ServicesCommercial Services Princeton Area Community Foundation is a charity organization that supports the health and well-being of communities. The non-profit company is based in Lawrenceville, NJ. Jeffrey Vega has been the CEO of the company since 2015. | 9 years |
Gerald Reynolds | M | - | 4 years | |
Labeeb M. Abboud | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Hilde Frafjord Johnson | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Raymond Murphy | M | 76 | 15 years | |
Michael Heffernan | M | 59 | 7 years | |
Robert Yedid | M | 66 | 5 years | |
James Cassella | M | 69 | 4 years | |
Barbara Hill | F | 71 | 11 years | |
Dominick Colangelo | M | 60 | 4 years | |
Christian Schade | M | 63 | 18 years | |
Ashwin Datt | M | - | 2 years | |
David Meeker | M | 69 |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | 11 years |
Nadia Waheed | M | 47 | 2 years | |
David Jacobs | M | - | 2 years | |
Rita McGrath | F | - |
McCarter Theatre Co.
| - |
Sharon Dietrich | F | - |
McCarter Theatre Co.
| - |
Thomas Richie | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Barney Graham | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Hope D'Oyley-Gay | F | - | 3 years | |
David Leslie Blumberg | M | 62 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Richard G. A. Feachem | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Angela Gómez de Mogollón | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Eneide Geiyer | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Sandi Glass | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Anne M. Simonds | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Raman Kapur | M | 78 |
McCarter Theatre Co.
| - |
Michael H. Ullmann | M | 66 |
Princeton Area Community Foundation
Princeton Area Community Foundation Miscellaneous Commercial ServicesCommercial Services Princeton Area Community Foundation is a charity organization that supports the health and well-being of communities. The non-profit company is based in Lawrenceville, NJ. Jeffrey Vega has been the CEO of the company since 2015. | 8 years |
Mark Dybul | M | 60 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Geeta Rao Gupta | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Abraham Scaria | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gregory Perry | M | 63 | 2 years | |
Andrei Floroiu | M | 51 | 4 years | |
Mary Szela | F | 60 | 1 years | |
Ben Harshbarger | M | 55 | 7 years | |
Peter Arduini | M | 59 | 11 years | |
John M. Harland | M | 71 | 5 years | |
Sandy Smith | M | 77 | 5 years | |
Jeryl Hilleman | F | 66 | 1 years | |
Susan B. Washer | F | 63 | 21 years | |
Marc Beer | M | 59 | 5 years | |
William A. Sullivan | M | 52 | 4 years | |
Todd Davis | M | 63 | 4 years | |
Ajay Bansal | M | 62 | 3 years | |
William Brown | M | 42 | 1 years | |
Annette Clancy | F | 70 | 10 years | |
Frank Verwiel | M | 62 | 6 years | |
John Bostjancic | M | 53 | - | |
Vipin K. Garg | M | 67 | 13 years | |
Roger W. Louis | M | 69 | 4 years | |
Gerard S. Carlozzi | M | 68 | 8 years | |
Linda Grais | M | 68 | 9 years | |
Margaret McGlynn | F | 64 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 4 years |
Neal Moszkowski | M | 58 | 14 years | |
Al Altomari | M | 65 |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | 8 years |
Geert Cauwenbergh | M | 70 |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | 7 years |
Katja Buhrer | F | - | 1 years | |
Jorge Plutzky | M | 65 | 2 years | |
Richard D. Gorelick | M | 63 | 18 years | |
Charles A. Baker | M | 91 |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | 11 years |
Eckard Weber | M | 73 | - | |
Sharon Tetlow | F | 64 | - | |
Donald Stern | M | 78 | 4 years | |
John Henneman | M | 62 | 16 years | |
James R. Altland | M | 75 | 7 years | |
Elke Bestel | M | 57 | 7 years | |
Rabia Ozden | M | 56 | 3 years | |
Marvin R. Haselhorst | M | - | - | |
Jane Waterman | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 10 years |
Rhonda L. Stanley | F | 64 | 4 years | |
Ivana Magovcevic-Liebisch | M | 55 | 8 years | |
Lars Ekman | M | 74 | 6 years | |
Gordana Košutic | M | 73 | 6 years | |
Brian O'Callaghan | M | 54 | 3 years | |
Helmut Thomas | M | 72 | 7 years | |
Scott Koenig | M | 71 | 20 years | |
Brenda D. Gavin | M | 76 | 6 years | |
David Guyer | M | 64 | 3 years | |
Lawrence E. Bullock | M | 67 | 3 years | |
Jerome Groopman | M | 72 | 11 years | |
Arnold Lewis Oronsky | M | 83 | 14 years | |
Edward Hurwitz | M | 60 | 10 years | |
John Johnson | M | 66 | 3 years | |
Sol Barer | M | 76 | 5 years | |
Barbara Duncan | F | 59 | 5 years | |
Pratik Shah | M | 54 | 9 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 91 | 91.00% |
Switzerland | 10 | 10.00% |
Canada | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anne VanLent
- Personal Network